Skip to main content

Table 1 Sociodemographic, clinical and laboratory characteristics of Rheumatoid Arthritis patients of the REAL study [19]

From: Cardiovascular risk comorbidities in rheumatoid arthritis patients and the use of anti-rheumatic drugs: a cross-sectional real-life study

Variables

n (%)

Gender (n = 1116)

 Female

998 (89.4)

Age – Mean (standard deviation) (n = 1116)

55.15 (21–88)

Education time (years) (n = 1076)

 0–4 years

301 (28)

 5–11 years

629 (58.4)

  ≥ 12 years

146 (13.6)

Disease duration (years) – mean (standard deviation) (n = 1116)

14.58 (1–57)

Erosive disease (n = 1096)

 Yes

602 (54.9)

DAS 28 VSH Scorea mean (standard deviation)

3.62 (0–8)

Smoking (n = 1116)

 Smoker

121 (10.8)

 Former Smoker

320 (28.7)

 Never Smoked

675 (60.5)

Rheumatoid Factor (n = 1098)

 Positive

863 (78.6)

ACPAb (n = 479)

 Positive

368 (768)

  1. aDisease Activity Score Index-28 Joints (DAS28); b Anti-citrullinated peptide antibody